Prof. Dr. Samuel S. Asculai - Bio-Strategies Consulting Group - Canada

Prof. Asculai has more than 35 years experience from the pharmaceutical, chemical and biotechnology industries.

Prof. Asculai is the founder and former CEO of Hyal Pharmaceutical Corporation. He lead the NASDAQ listing and IPO of Hyal's Australian subsidiary, and increased Hyal's market capitalization from $5 million to $250 million.

Prof. Asculai has managed R&D organizations both within the Johnson & Johnson and Monsanto groups.

To contact Prof. Samuel S. Asculai please use the following email: egalitrac@aol.com